Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
GPCR Desensitization01:12

GPCR Desensitization

5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

386
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
386

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic and proximal tubule specific knockout of <i>Arhgef11</i> and impact on hypertension and kidney injury.

Physiological genomics·2026
Same author

Sex-specific rat placental molecular responses to G protein-coupled estrogen receptor (GPER) activation.

Placenta·2026
Same author

CD4<sup>+</sup> T cell protection against murine Salmonella infection is female-specific and estrogen-dependent.

Nature communications·2026
Same author

Sex-dependent differences in bioenergetics of young mouse brain microvasculature: implications for oxygen-glucose deprivation and reoxygenation injury.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Peptidyl-tRNA hydrolase 2 is a negative regulator of peripartum cardiomyopathy with heart failure in female mice.

Nature communications·2025
Same author

Near-infrared-II pulsed laser diode array for spectral photoacoustic imaging of deep tissue oxygenation.

Biomedical optics express·2025

Related Experiment Video

Updated: May 13, 2025

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
05:17

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy

Published on: April 5, 2024

642

Pregnancy-Dependent Cardioprotection via GPER Activation in Dahl Salt-Sensitive Rats.

Allan K N Alencar, Kenneth F Swan, Mistina M Manoharan

    Biorxiv : the Preprint Server for Biology
    |April 16, 2025
    PubMed
    Summary

    A GPER agonist, LNS8801, improved heart function and reduced proteinuria in pregnant rats with hypertension. Pregnancy adaptations enhanced GPER

    More Related Videos

    Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
    10:28

    Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

    Published on: December 5, 2017

    9.2K
    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.2K

    Related Experiment Videos

    Last Updated: May 13, 2025

    Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
    05:17

    Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy

    Published on: April 5, 2024

    642
    Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
    10:28

    Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

    Published on: December 5, 2017

    9.2K
    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.2K

    Area of Science:

    • Cardiovascular physiology
    • Endocrinology
    • Pharmacology

    Background:

    • Preeclampsia poses long-term cardiovascular risks due to pregnancy-induced cardiac dysfunction.
    • The role of G protein-coupled estrogen receptor (GPER) in pregnancy-associated cardiac dysfunction is unclear.
    • Hormonal fluctuations and hemodynamic changes during pregnancy influence cardiovascular adaptations.

    Purpose of the Study:

    • To investigate the cardioprotective effects of LNS8801, a GPER agonist, in pregnant and virgin hypertensive rats.
    • To assess LNS8801's impact on cardiac function and blood pressure in a preeclampsia model.
    • To determine if pregnancy adaptations modulate GPER-mediated cardioprotection.

    Main Methods:

    • Dahl salt-sensitive (SS/Jr) rats, virgin and pregnant, received LNS8801 or vehicle.
    • Cardiac function was evaluated using echocardiography and speckle-tracking strain analysis.
    • Mean arterial pressure and proteinuria were measured to assess systemic effects.

    Main Results:

    • LNS8801 significantly improved cardiac function (systolic and diastolic) and strain parameters in pregnant rats.
    • LNS8801 reduced proteinuria in both virgin and pregnant rats, suggesting renal protective effects.
    • No significant effects of LNS8801 on cardiac function or blood pressure were observed in virgin rats.

    Conclusions:

    • Pregnancy-specific adaptations enhance GPER-mediated cardioprotection.
    • LNS8801 shows potential as a therapeutic agent for pregnancy-associated cardiovascular dysfunction.
    • Targeting GPER requires consideration of the unique physiological environment of pregnancy.